31 Jan 2024
31 January 2024: Trilegal represented Naspers Ventures B.V. (Naspers Ventures) in securing an unconditional approval from the Competition Commission of India (CCI) in relation to the proposed follow-on investment in API Holdings Limited (API). The CCI approved the transaction on 30 January 2024.
Trilegal represented Naspers Ventures on the Indian competition law aspects of the transaction and filed a merger notification with the CCI. Trilegal demonstrated that the proposed transaction would not cause any appreciable adverse effect on competition in India in any of the relevant markets.
Naspers Ventures, incorporated in Netherlands, is an investment holding company indirectly owned by Naspers Limited. Naspers Limited is a global consumer internet company and one of the leading technology investors and operators in the world. API is engaged in various activities in the pharmaceutical and healthcare sector in India and owns the ‘Pharmeasy’ platform.
Trilegal competition team was led by Nisha Kaur Uberoi, Partner & National Head – Competition Law and Gautam Chawla, Partner; and assisted by Divye Sharma, Counsel; Reshabh Juneja, Senior Associate; Vasudha Verma and Giri Aravind, Associates.
Cyril Amarchand Mangaldas advised API on corporate law aspects of the transaction.
For more information, please contact:
Roomi Irani
Mob: +912240791000 | BD@trilegal.com
Estate planning: What is a settlement deed? Can it override a will? We explain
Deal: Trilegal advises Macquarie Corporate Holdings on the sale of Vibrant Energy to Inox Clean Energy
Deal: Trilegal advises Elliott Investment Management L.P. on CCI approval for its significant investment in Toyota Industries Corporation
Under the rules of the Bar Council of India, Trilegal is prohibited from soliciting work or advertising in any form or manner. By accessing this website, www.trilegal.com, you acknowledge that:
We prioritize your privacy. Before proceeding, we encourage you to read our privacy policy, which outlines the below, and terms of use to understand how we handle your data:
For more information, please read our terms of use and our privacy policy.
